AL
GSK icon

Airain Ltd’s GSK GSK Stock Holding History

Airain Ltd’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$9.82M Buy
182,130
+55,568
+44% +$2.96M 0.43% 63
2017
Q1 		$6.67M Buy
126,562
+101,276
+401% +$5.14M 0.33% 89
2016
Q4 		$1.22M Buy
+25,286
New +$1.25M 0.1% 206
2016
Q1 		– Sell
-61,692
Closed -$3.11M – 896
2015
Q4 		$3.11M Buy
+61,692
New +$3.14M 0.21% 127

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Airain Ltd's GSK Position: Q2 2017 in Review

Airain Ltd increased its GSK (GSK) stake by 44% in Q2 2017, buying an estimated $2.96M and bringing the position to 182,130 shares worth $9.82M. The position accounts for 0.43% of the portfolio, ranked #63.

Airain Ltd first reported a position in GSK in Q4 2015 and has held it in 4 quarters since. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

  • Airain Ltd held 182,130 shares of GSK worth $9.82M as of Q2 2017.
  • Airain Ltd bought 55,568 GSK shares in Q2 2017, an estimated $2.96M.
  • GSK made up 0.43% of Airain Ltd's portfolio in Q2 2017, its #63 holding.
  • Airain Ltd first reported a position in GSK in Q4 2015 and has held it in 4 quarters since.
  • 779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.